ALLIANCE FOR TOBACCO CESSATION:

1
ALLIANCE FOR TOBACCO CESSATION OVERVIEW OF
THE CESSATION SUBCOMMITTEE OF THE INTERAGENCY
COMMITTEE ON SMOKING AND HEALTH Matt
Barry Senior Policy Analyst Campaign for Tobacco
Free Kids November 19, 2002
2
WHAT IS THE INTERAGENCY COMMITTEE ON SMOKING AND
HEALTH (ICSH)?

• The ICSH was established by Congress on April 19,
  1985 under the authority of the Comprehensive
  Smoking Education Act for 1984 (P.L. 98-474).
• According to the statute, the purpose of the ICSH
  is to
• coordinate the research and educational programs
  of HHS related to the effect of smoking on human
  health with the activities of other government
  and private agencies and
• establish and maintain a liaison with appropriate
  private entities, other government agencies
  regarding activities related to the effects of
  smoking on human health.

3
WHAT IS THE CESSATION SUBCOMMITTEE OF THE ICSH?

• Originated out of meeting of full ICSH on
  cessation at August 2001 meeting.
• The Cessation Subcommittee is charged with making
  recommendations on how best to promote tobacco
  use cessation.
• The Subcommittee will develop and submit to the
  Secretary of HHS a report that contains action
  steps for both a Secretarial initiative and
  public-private partnerships to best promote
  tobacco use cessation.

4
SUBCOMMITTEE MEMBERS

• Chair - Michael Fiore, M.D., M.P.H. (Univ. WI)
• Robert T. Croyle, Ph.D. (NCI)
• Susan J. Curry, Ph.D. (UI- Chicago)
• Charles M. Cutler, M.D., M.S. (AAHP)
• Ronald Davis, M.D. (AMA)
• Catherine Gordon, R.N., M.B.A. (CMS)
• Cheryl Healton, Dr.PH (ALF)
• Rosemarie Henson, M.S.S.W, M.P.H. (CDC/OSH)
• Howard Koh, M.D., M.P.H., FACP (MA DPH)
• James Marks, M.D., M.P.H. (CDC/NCCDPHP)
• Tracy Orleans, Ph.D. (RWJF)
• Dennis Richling, M.D. (UP Railroad)
• David Satcher, M.D. (Morehouse)
• John Seffrin, Ph.D. (ACS)
• Christine Williams (AHRQ)
• Larry N. Williams, DDS, MAGD (USN)

5
THE EVIDENCE BASE FOR THE SUBCOMMITTEE

• the PHS Clinical Practice Guideline Treating
  Tobacco Use and Dependence
• the U.S. Task Force on Community Preventive
  Services Guide to Community Preventive Services
  Tobacco Use Prevention and Control
• the ICSH Action Plan on Tobacco Use Cessation,
  and
• the National Blueprint for Disseminating and
  Implementing Evidence-Based Clinical and
  Community Strategies to Promote Tobacco Use
  Cessation.
• These four documents are related to objectives to
  promote tobacco use cessation in four different
  areas clinicians, health care systems,
  communities and consumers.

6
KEY SUBCOMMITTEE OBJECTIVES

• Obtain input and support from influential
  individuals and organizations regarding
  opportunities to promote tobacco use cessation,
  barriers to promote cessation, and
  recommendations for overcoming those barriers.
• Transmit a report to the Secretary that outlines
  specific action steps for HHS to promote tobacco
  use cessation and overcome identified barriers
  that will be implemented in 2003 and subsequent
  years.

7
PUBLIC HEARINGS

• The Subcommittee will hold three public meetings
  this fall to obtain input from key audiences on
• evidence-based opportunities to promote tobacco
  use cessation,
• evidence-based strategies to overcome barriers
  and challenges faced by your group to ensure
  tobacco use cessation is promoted, and
• evidence-based support DHHS could provide to
  promote cessation, either through Federal
  initiatives or through fostering public-private
  partnerships.

8
TOBACCO CONTROL COMMUNITYS RESPONSE TO PUBLIC
HEARINGS

• Emphasize need to be comprehensive, focus on both
  population-based (excise taxes, CIA laws) and
  individual cessation services (counseling and
  drugs) in order to increase demand for services
  among tobacco users.
• Need for HHS to demonstrate leadership (begin
  with coverage of cessation under Medicaid and
  Medicare).
• Need for tobacco control community to show broad
  support for cessation - traditional health care
  groups, groups representing under-represented
  populations (low income, racial and ethnic
  minorities), smokers, health plans, businesses,
  and providers.

9
ROLE OF THE ALLIANCE IN PUBLIC HEARINGS

• Developed a background document on
  recommendations organizations could make to the
  Subcommittee (copies are available upon request).
• Information was sent to the tobacco control,
  prevention, research and cessation communities
  about the hearings in an effort to get more
  organizations and individuals to provide
  testimony.

10
THEMES FROM OCTOBER 24 HEARING IN WASHINGTON, DC

• Comprehensive
• Quitlines with no barriers
• Excise tax increases
• Education of health care professionals
• FDA product regulation
• HHS to lead by example
• Need for more research

11
GROUPS/VOICES NOT YET HEARD BUT NEEDED TO
SPEAK/SUBMIT TESTIMONY

• Business leaders
• Purchasers and Insurers
• Elected officials
• Community service organizations
• Representatives from diverse, affected
  populations
• Smokers
• Senior citizens
• Military/VA
• Health care delivery systems
• Safety net providers
• Medicaid agencies

12
LOCATION OF PUBLIC HEARINGS
October 24 - Washington, DC November 14 - Denver,
CO December 3 - Chicago, IL You can also submit
written comments to CDC/OSH until December 20,
2002.
13
FOR MORE INFORMATION ON THE SUBCOMMITTEE
Visit - http//www.cdc.gov/tobacco/ICSH/subcommit
tee.htm or If you would like to attend and/or
speak at the public meetings, and/or submit
written comments for the record, contact Jessica
Porras of CDC/OSH by phone [phone]), fax
(202-205-8313) or email (jporras_at_cdc.gov).